Detalhe da pesquisa
1.
Surveillance of pfhrp2 and pfhrp3 gene deletions among symptomatic Plasmodium falciparum malaria patients in Central Vietnam.
Malar J
; 21(1): 371, 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471315
2.
High Proportion of Genome-Wide Homology and Increased Pretreatment pvcrt Levels in Plasmodium vivax Late Recurrences: a Chloroquine Therapeutic Efficacy Study.
Antimicrob Agents Chemother
; 65(8): e0009521, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031050
3.
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria.
Malar J
; 20(1): 222, 2021 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011358
4.
Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam.
J Antimicrob Chemother
; 75(8): 2272-2281, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437557
5.
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker.
Malar J
; 18(1): 126, 2019 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967148
6.
Micro-epidemiology of malaria in an elimination setting in Central Vietnam.
Malar J
; 17(1): 119, 2018 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29554901
7.
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
Emerg Infect Dis
; 23(4): 715-717, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28322709
8.
A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
BMC Med
; 15(1): 181, 2017 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988541
9.
Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.
Antimicrob Agents Chemother
; 59(12): 7411-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26392501
10.
Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir.
Malar J
; 14: 86, 2015 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880664
11.
Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam.
Emerg Infect Dis
; 20(7): 1199-202, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24963881
12.
Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.
Antimicrob Agents Chemother
; 58(12): 7049-55, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25224002
13.
Study protocol for development of an options assessment toolkit (OAT) for national malaria programs in Asia Pacific to determine best combinations of vivax radical cure for their given contexts.
PLoS One
; 18(3): e0280950, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893173
14.
Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam.
Emerg Infect Dis
; 21(7): 1265, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26079727
15.
Identification of Fasciola Species Isolates from Nghe An Province, Vietnam, Based on ITS1 Sequence of Ribosomal DNA Using a Simple PCR-RFLP Method.
J Parasitol Res
; 2018: 2958026, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30631590
16.
Risk factors for Clonorchis sinensis infection transmission in humans in northern Vietnam: A descriptive and social network analysis study.
Parasitol Int
; 66(2): 74-82, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27939296
17.
Population Genetics of Plasmodium vivax in Four Rural Communities in Central Vietnam.
PLoS Negl Trop Dis
; 10(2): e0004434, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26872387
18.
Assessment of anthelmintic efficacy of mebendazole in school children in six countries where soil-transmitted helminths are endemic.
PLoS Negl Trop Dis
; 8(10): e3204, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25299391